MSUS has emerged as an invaluable diagnostic and prognostic tool in rheumatology, often complementing clinical evidence to bolster its role in managing patients with rheumatoid arthritis or juvenile idiopathic arthritis. During the 28^th Hong Kong Medical Forum, Dr. Ho, Tze-Kwan Carmen shared her insights on the implementation of MSUS and the interpretation of its results in gout management.

Psoriatic arthritis (PsA) is a complex inflammatory disease that can be challenging to diagnose due to its heterogeneous clinical features.1,2 While diagnosis is commonly made through the identification of inflammatory musculoskeletal features in the presence of skin and/or nail psoriasis, no univer